Journal profile · Medicine-Surgery
JBJS Open Access
ISSN 2472-7245 · Wolters Kluwer Health · United States
JBJS Open Access: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4.9 (journal website); JCR Q1 (journal website); fully open access; APC about USD 2,250; review about 6 weeks (community reports); 224 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
JBJS Open Access is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Total Knee Arthroplasty Outcomes, Diversity and Career in Medicine and Orthopaedic implants and arthroplasty, together about 31.6% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Above-elbow amputation results in profound functional and psychosocial impairments. Modern bionic reconstruction has improved outcomes in these patients, but several limitations remain. In situations where the hand remains unaffected by trauma or tumor, segmental limb resection followed by immediate replantation offers a viable alternative to amputation. However, comparative functional outcome data between these approaches are lacking. To guide clinical decision-making, this study aimed to compare functional outcomes after resection-replantation (RR) and modern bionic reconstruction (BR) at the transhumeral level.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Surgery
Editor-in-chief Eng Hin LeePublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Total Knee Arthroplasty OutcomesMedicine13.2%
- Diversity and Career in MedicineSocial Sciences10.6%
- Orthopaedic implants and arthroplastyMedicine7.9%
- Bone fractures and treatmentsMedicine5.9%
- Shoulder Injury and TreatmentMedicine5.7%
- Surgical Simulation and TrainingMedicine5.5%
- Orthopedic Infections and TreatmentsMedicine5.4%
- Hip and Femur FracturesMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Orthopedics | Zone 4 |
| Minor | Surgery | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Orthopedics | Zone 2 |
| Minor | Surgery | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q1 · ORTHOPEDICS · rank 11/147
- JCR Q1 · SURGERY · rank 20/321
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 4.9Publisher website ·
- CiteScore 2026-06
- 4.9LetPub ·
- SJR 2026-06
- 1.67LetPub ·
- SNIP 2026-06
- 2.4LetPub ·
- h-index
- 40OpenAlex ·
- i10-index
- 248OpenAlex ·
- 2-year mean citedness
- 1.69OpenAlex ·
- Self-citation rate
- 8.2%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 209LetPub ·
Articles by year OpenAlex count · 915 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 165 | 165 | 42 |
| 2025 | 224 | 224 | 305 |
| 2024 | 97 | 97 | 472 |
| 2023 | 98 | 98 | 1,596 |
| 2022 | 67 | 67 | 647 |
| 2021 | 83 | 83 | 1,602 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 6 weeksLetPub ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,250 | No | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,250 | — | — | |
| LetPub | USD 2,250 | No | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review, Trial registration / reporting guidelines
- Peer review
Journal ranking in categories ORTHOPEDICS (11/147) and SURGERY (20/321) Model summary
Ranking: ORTHOPEDICS: 11/147; SURGERY: 20/321
Source ↗Publisher website ·- Trial registration / reporting guidelines Trial Registration:
Clinical trial status—open-label prospective trial registered at ClinicalTrials.gov: NCT04167163
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- United States
- Language
- English
- ISSN
- 2472-7245
- Latest issue on the website
- Volume 11, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about JBJS Open Access
What CAS zone is JBJS Open Access in?
In the 2025 upgraded edition of the CAS Journal Ranking, JBJS Open Access is in Zone 4 of Medicine, and in Zone 4 of the minor category Orthopedics / Surgery. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of JBJS Open Access?
The journal's website gives an impact factor of 4.9; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.9, h-index 40.
How long does peer review take at JBJS Open Access?
Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is JBJS Open Access in?
The journal's website gives JCR Q1; by category, ORTHOPEDICS Q1 (11/147), SURGERY Q1 (20/321). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index JBJS Open Access?
According to LetPub and DOAJ records, JBJS Open Access is indexed in ESCI, Scopus and DOAJ.
Is JBJS Open Access open access, and what is the APC?
JBJS Open Access is a fully open-access journal. APC about USD 2,250.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .